Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420

PURPOSE: We conducted a phase II trial to evaluate the efficacy and safety of single-agent sorafenib in chemotherapy-naïve patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN). The primary end point was response probability (ie, confirmed complete and partial re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Williamson, Stephen K., Moon, James, Huang, Chao H., Guaglianone, Perry P., LeBlanc, Michael, Wolf, Gregory T., Urba, Susan G.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2010
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903329/
https://ncbi.nlm.nih.gov/pubmed/20498388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.6834
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars